Join
Live feed
·
PRReleasevia Quantisnow
Biomerica Inc. logo

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

ByQuantisnow·Wall Street's wire, on your screen.
BMRA· Biomerica Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMRA (Biomerica Inc.) and more on Quantisnow.